Mid-Florida Infectious Disease is categorized under Infectious Disease Specialists in Orlando, FL and active since 2008.
Mid-Florida Infectious Disease was established in 2008, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Infectious Disease Specialists business, which does work in the B2C market, and is classified as a Infectious Disease Specialists, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Isis Mc New at the company’s single location by writing to 1414 Virginia Drive, Orlando, Florida FL 32803 or by phoning (407) 894-6618. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Mid-Florida Infectious Disease |
Contact Person: | Isis Mc New |
Address: | 1414 Virginia Drive, Orlando, Florida 32803 |
Phone Number: | (407) 894-6618 |
Annual Revenue (USD): | $1.000.000 to $2.499.999 |
Founded: | 2008 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Infectious Disease Specialists |
SIC Code: | 8011 |
NAICS Code: | 6211110 |
Share This Business: |
Mid-Florida Infectious Disease was started in 2008 to provide professional Infectious Disease Specialists under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.
Feel free to contact Isis Mc New for inquiries that concern Mid-Florida Infectious Disease by calling the company number (407) 894-6618, as your correspondence is most welcome. Additionally, the physical location of the single location of Mid-Florida Infectious Disease can be found at the coordinates 28.563918,-81.361724 as well as the street address 1414 Virginia Drive in Orlando, Florida 32803.
For its online presence, you may visit Mid-Florida Infectious Disease’s website at and engage with its social media outlets through on Twitter and on Facebook.